flucytosine and arginyl-glycyl-aspartic acid

flucytosine has been researched along with arginyl-glycyl-aspartic acid in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Akbulut, H; Deisseroth, A; Liu, Y; Maynard, J; Ye, T	1
Borgstrom, P; Deisseroth, A; Koziol, J; Liu, Y	1

Other Studies

2 other study(ies) available for flucytosine and arginyl-glycyl-aspartic acid

Article	Year
Engineering conditionally replication-competent adenoviral vectors carrying the cytosine deaminase gene increases the infectivity and therapeutic effect for breast cancer gene therapy. Cancer gene therapy, 2006, Volume: 13, Issue:4 Topics: Adenoviridae; Adenovirus E1A Proteins; Animals; Antimetabolites, Antineoplastic; Cell Line, Tumor; Cell Proliferation; Cytosine Deaminase; Female; Flucytosine; Genetic Therapy; Genetic Vectors; Humans; Integrin alphaVbeta3; Integrins; Mammary Neoplasms, Experimental; Membrane Glycoproteins; Microfilament Proteins; Oligopeptides; Phosphoproteins; Promoter Regions, Genetic; Receptors, Vitronectin; Transduction, Genetic	2006
Methods for delivery of adenoviral vectors to tumor vasculature. Human gene therapy, 2007, Volume: 18, Issue:2 Topics: Adenoviridae; Animals; BALB 3T3 Cells; Flucytosine; Fluorescent Antibody Technique; Gene Transfer Techniques; Genetic Vectors; Green Fluorescent Proteins; Humans; Hydroxyethyl Starch Derivatives; Injections, Intraperitoneal; Injections, Intravenous; Liver; Luciferases; Mice; Mice, Nude; Neoplasms; Oligopeptides; Skin; Spheroids, Cellular; Tumor Cells, Cultured	2007

Article

Year

Engineering conditionally replication-competent adenoviral vectors carrying the cytosine deaminase gene increases the infectivity and therapeutic effect for breast cancer gene therapy.

Cancer gene therapy, 2006, Volume: 13, Issue:4

Topics: Adenoviridae; Adenovirus E1A Proteins; Animals; Antimetabolites, Antineoplastic; Cell Line, Tumor; Cell Proliferation; Cytosine Deaminase; Female; Flucytosine; Genetic Therapy; Genetic Vectors; Humans; Integrin alphaVbeta3; Integrins; Mammary Neoplasms, Experimental; Membrane Glycoproteins; Microfilament Proteins; Oligopeptides; Phosphoproteins; Promoter Regions, Genetic; Receptors, Vitronectin; Transduction, Genetic

2006

Methods for delivery of adenoviral vectors to tumor vasculature.

Human gene therapy, 2007, Volume: 18, Issue:2

Topics: Adenoviridae; Animals; BALB 3T3 Cells; Flucytosine; Fluorescent Antibody Technique; Gene Transfer Techniques; Genetic Vectors; Green Fluorescent Proteins; Humans; Hydroxyethyl Starch Derivatives; Injections, Intraperitoneal; Injections, Intravenous; Liver; Luciferases; Mice; Mice, Nude; Neoplasms; Oligopeptides; Skin; Spheroids, Cellular; Tumor Cells, Cultured

2007